Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 21 ~ 40 of 25905, Page 2 of 1296
21. Women with Coronary Artery Wall Thickness at Risk for Heart Disease
Researchers used CCTA and Framingham scores to assess coronary artery disease in 62 women and 62 men at low to intermediate risk of heart disease. / Vessel wall thickness, as measured by MRI, was the strongest variable associated with coronary artery disease in women. / The results point to a potential future role for vessel wall thickness measurements in identifying opportunities for early lifestyle changes or treatment.
04/25/2019 Radiological Society of North America
22. Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA® (pembrolizumab) as Monotherapy and in Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
04/25/2019 MERCK
23. The Health Benefits of Owning Pets
Many Americans love their dogs, cats, hamsters, fish, birds, snakes, and other pets. Find out how your furry, feathered, and scaly friends can help you stay well ? and what you may need to watch out for.
04/25/2019 American Cancer Society
24. Merck and Viola Davis to Debut A Touch of Sugar During Tribeca Film Festival®
Acclaimed Actress Narrates Documentary Aimed at Confronting America’s Type 2 Diabetes Crisis
04/25/2019 MERCK
25. To grow up healthy, children need to sit less and play more
New WHO guidelines on physical activity, sedentary behaviour and sleep for children under 5 years of age
04/24/2019 WHO
26. Risk of Venous Thromboembolism After Shoulder Surgery
How physicians and patients can work together to help mitigate complications
04/24/2019 American Academy of Orthopaedic Surgeons
27. Malaria vaccine pilot launched in Malawi
Country first of three in Africa to roll out landmark vaccine / An innovation milestone, three decades in development / A model public-private partnership
04/23/2019 WHO
28. Obesity Linked with Differences in Form and Structure of the Brain
MRI shows that higher levels of body fat are associated with differences in the brain's form and structure. / Brain imaging results from more than 12,000 participants in the UK Biobank study were analyzed. / Researchers found that higher total body fat percentage increased the likelihood of changes to the brain's white matter. In men, gray matter volume was also reduced.
04/23/2019 Radiological Society of North America
29. Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health, on new steps to help reduce risks associated with surgical staplers for internal use and implantable staples
04/23/2019 U.S. FOOD & DRUG ADMINISTRATION
30. The Link Between Weight and Cancer Risk
Being overweight or obese puts you at greater risk for some types of cancer. Learn about the connection between weight and cancer ? and what you can do about it.
04/23/2019 American Cancer Society
31. Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recalls
04/23/2019 U.S. FOOD & DRUG ADMINISTRATION
32. Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine
04/22/2019 U.S. FOOD & DRUG ADMINISTRATION
33. FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Inlyta® (axitinib) as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma (RCC)
Approval Based on Results of KEYNOTE-426, Where KEYTRUDA in Combination With Axitinib Reduced the Risk of Death by Nearly Half Compared to Sunitinib
04/22/2019 MERCK
34. FDA permits marketing of first medical device for treatment of ADHD
04/19/2019 U.S. FOOD & DRUG ADMINISTRATION
35. FDA approves first generic naloxone nasal spray to treat opioid overdose
Agency is also taking new steps to support development of over-the-counter and additional generics of naloxone to help reduce opioid overdose deaths, increase access to emergency treatment
04/19/2019 U.S. FOOD & DRUG ADMINISTRATION
36. WHO releases first guideline on digital health interventions
Digital health interventions are not sufficient on their own /
04/17/2019 WHO
37. Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease
Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease.
04/17/2019 Medtronic
38. Medtronic Data Expands on Key Aortic Solutions for Challenging Anatomies
New EndoSuture Aneurysm Repair (ESAR) and Valiant Navion(TM) Data Presented at Charing Cross Demonstrate Safety and Efficacy in Patients with Complex Anatomies
04/17/2019 Medtronic
39. Abbott Reports First-Quarter 2019 Results
ABBOTT PARK, Ill., April 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2019.
04/17/2019 Abbott
40. FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to remove all devices from the market
04/16/2019 U.S. FOOD & DRUG ADMINISTRATION
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱